Skip to main content
. Author manuscript; available in PMC: 2018 Aug 15.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):e128–e131. doi: 10.1097/QAI.0000000000001384

Table 2.

Infant Characteristics and Cepheid POC Result for HIV-Positive Infants

Baby Child Baseline CD4 Child Baseline VL Age at first AZT/NVP dose (Hours)* Age at Screening (Hours) Point-of-Care Result
A 5,159 1,661 114.5 18.5 Negative
B 1,995 17,244 25.3 13.6 Positive
C 1,854 1,636 21.3 25.5 Positive
D 1,021 1,111,950 7.0 15.9 Positive
E 1,556 1,375 2.4 9.8 Positive
F 1,748 >10,000,000 29.9 6.6 Positive
G 1,634 <40 0.2 39.2 Positive
H 1,950 60,247 3.5 19.9 Positive
I 1,671 3,145 4.2 40.1 Positive
J 2,616 1,005 1.6 44.8 Positive
K 2,177 272 23.0 36.5 Positive
L 1,066 1,314 0.2 32.0 Positive
M 1,469 23,686 0.7 6.6 Positive
N 1,601 20,291 27.3 14.2 Positive
O --- --- --- --- Positive
Median 1,709.5 2,403 5.6 19.2
*

Single-dose NVP (10–15 mg PO) and daily AZT (4mg/kg PO twice daily)

Time estimated based on delivery

Infant did not receive NVP